In vitro assessments of antimicrobial activity - task area b
Ended Awarded Last action
- Contract number
- 75N93019D00021
- Awardee
-
Utah State University UEI SPE2YDWHDYU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 16 $7,237,597 obligated
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017091 Solicitation number
- In Vitro Assessments of Antimicrobial Activity Award Notice · Posted Nov 14, 2017
- Combined order value
-
- $7,237,597 Current, with exercised options
- $9,505,436 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 24% used
- $30,000,000.00
- Maximum order
- $30,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 27 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a multiple-award indefinite delivery contract valued at $30 million to Utah State University for in vitro assessments of antimicrobial activity, with a performance period extending through January 22, 2026. No set-aside was utilized for this award. Utah State University, a 1862 land-grant public research institution, serves as the prime contractor and will perform work primarily at its facilities in Logan, Utah, with some activities conducted in Driggs, Idaho. The contract encompasses comprehensive viral screening, antiviral compound testing, and antimicrobial activity assessments supporting NIAID's mission to develop and evaluate countermeasures including vaccines, therapeutics, and diagnostics against priority infectious agents. The scope includes in vitro testing of experimental antiviral compounds to determine antiviral inhibitory effects and cytotoxicity across various virus groups, respiratory pathogen screening, and pandemic potential virus assessment under the Antiviral Program for Pandemics.
Since contract inception in January 2019, NIAID has issued multiple firm fixed-price delivery orders totaling approximately $9.5 million against this indefinite delivery vehicle, representing active utilization of the contract's $30 million ceiling. Delivery orders have addressed specialized requirements including comprehensive viral screening panels, in vitro antiviral screening against biosafety level 4 pathogens, assessment of compounds against respiratory viruses and pandemic potential agents, testing of experimental antivirals against virus groups 3-7, and screening of monkeypox and ectromelia viruses. The most recent task orders, issued in September 2024 and December 2024, valued at $339,045 and $653,618 respectively, demonstrate continued utilization for respiratory virus antimicrobial assessments and comprehensive viral screening panel services. Utah State University's specialized laboratory capabilities, established expertise in infectious disease research, and advanced testing infrastructure position the institution to support NIAID's critical biodefense and public health preparedness initiatives through the delivery of specialized virology screening and countermeasure evaluation services.
Task orders
Show all 16
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93019D00021?
75N93019D00021 was awarded to Utah State University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 11, 2019.
How much is contract 75N93019D00021 worth?
Orders under 75N93019D00021 have obligated $7,237,597. Their combined potential value, with all options, is $9,505,436. 75N93019D00021's own ceiling is $30,000,000. A single order can be worth up to $30,000,000.
How many orders have been placed under contract 75N93019D00021?
16 orders have been placed under 75N93019D00021, the latest on December 16, 2024.
Who can order from contract 75N93019D00021?
75N93019D00021 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93019D00021 part of a contract vehicle?
Yes. 75N93019D00021 is part of In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93019D00021 competed?
The extent of competition for 75N93019D00021 was full and open competition. The government received 27 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV